Clinical Focus

Previous Articles     Next Articles

Association of COFNLR with clinicopathological characteristics and prognosis of patients with nonsmallcell lung cancer after curative resection

  

  1. Department of Clinical Laboratory, People’s Hospital of Qian’an,Qian’an 064400,China
  • Online:2016-07-05 Published:2016-07-08
  • Contact: Corresponding author:Hao Yujie,Email: haoyujie888@126.com

Abstract: Objective  To analyze the combination of preoperative plasma levels of fibrinogen(Fbg) and neutrophiltolymphocyte ratio (COFNLR) with clinicopathologic characteristics as well as the prognosis of nonsmallcell lung cancer (NSCLC) patients after curative resection. Methods  The clinical data of 122 patients with NSCLC who underwent curative resection in our hospital were retrospectively analyzed. A total of  122 patients with NSCLC were divided into three groups based on the criteria of COFNLR: COFNLR 0 group, n=49; COFNLR1 group, n=41; COFNLR2 group, n=32.  The preoperative COFNLR was calculated by combing the fibrinogen and neutrophiltolymphocyte ratio (NLR). The relationship between the COFNLR and clinicopathological features was studied by chisquare test. The postoperative prognostic factors were analyzed using univariate KaplanMeier analysis and multivariate Cox proportional hazards model. Results  The COFNLR was significantly associated with sex, differentiation degrees, T staging, clinical staging(P<0.05). Univariate analysis showed smoking history, differentiation degrees, T staging, lymph node metastasis, plasma levels of fibrinogen,NLR  and  COFNLR were associated with survival (P<0.05). Multivariate analysis identified that differentiation degrees, lymph node metastasis and COFNLR as independent prognostic factors of all the patients(all P<0.05).Conclusion  Preoperative elevated plasma level of COFNLR indicates tumor progression and poor prognosis in patients with NSCLC. The COFNLR may be a potentially new and useful blood marker for predicting tumor progression and the prognosis of patients with NSCLC.

Key words: carcinoma, nonsmallcell lung cancer, fibrinogen, neutrophil infiltration, lymphocytes, prognosis